home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

abnormal gene silencing may lead to breast cancer progression

  November, 17 2000 1:04
your information resource in human molecular genetics
Emory researchers report abnormal gene silencing may lead to breast cancer progression

Emory University scientists have discovered that a mistake in the way DNA is labeled and packaged by methyltransferase enzymes could lead to the abnormal silencing of TMS-1, a gene that plays an important role in keeping breast cancer cells in check, thus contributing to breast cancer progression.

Holly Korschun
Emory University Health Sciences Center

Message posted by: Wouter Kalle

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.